Leucocyte activation by anti-lactoferrin antibodies bound to vascular endothelium

Clinical and Experimental Immunology

Volumn 103, Issue 3, 1996, Pages 403-407

  Peen, E ^a,b   Sundqvist, T ^b   Skogh, T ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ANCA; Anti lactoferrin antibodies; Endothelial cells; Granulocyte activation; Lactoferrin

Indexed keywords

AUTOANTIBODY; FORMYLMETHIONYLLEUCYLPHENYLALANINE; IMMUNOGLOBULIN G; LACTOFERRIN; LACTOFERRIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CHEMOLUMINESCENCE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030001927     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1996.tb08294.x     Document Type: Article

References (34)

1. Hagen EC, Ballieux BEPD, van Es LA, Daha MR, van der Woude FJ. Antineutrophil cytoplasm antibodies: a review of the antigens involved in the assays, and the clinical and possible pathogenetic consequences. Blood 1993; 81:1996-2002.
2. Jenette, JC, Ewert BH, Falk RJ. Do antineutrophil cytoplasmic autoantibodies cause Wegener's granulomatosis and other forms of necrotizing vasculitis? Rheum Dis Clin N Am 1993; 19:114.
3. Brouwer E. Pathogenic potential of antineutrophil cytoplasmic antibodies. MD thesis, Groningen 1994.
4. Skogh T, Dahlgren C, Holmgren K, Peen E, Stendahl O. Anti-granulocyte antibodies (C-ANCA, P-ANCA, GS-ANA) studied by confocal scanning laser fluorescence microscopy, ELISA, and chemiluminescence techniques. Scand J Immunol 1991; 34:137-45.
5. Cramer E, Pryzwansky KB, Villeval JL, Testa U, Breton-Gorius J. Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immuno-gold. Blood 1985; 65:423-32.
6. Lash JA, Coates D, Lafuze J, Baehner RL, Boxer LA. Plasma lactoferrin reflects granulocyte activation in vivo. Blood 1983; 61:885-8.
7. van Snick JL, Masson PL, Heremans JF. The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med 1974; 140:1068-84.
8. Courtoy PJ, Moguilevsky N, Retegui LA, Castracane CE, Masson PL. Uptake of lactoferrin by the liver. II Endocytosis by sinusoidal cells. Lab Invest 1984; 50:329-34.
9. Ziere GJ, van Dijk MCM, Bijsterbosch MK. van Berkel TJC. Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J Biol Chem 1992; 267:11229-35.
10. Oseas R, Yang HH, Baehner RL, Boxer LA. Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness. Blood 1981; 57:939-45.
11. Boxer LA, Björkstén B, Björk J, Yang HH, Alien JM, Baehner RL. Neutropenia induced by systemic infusion of lactoferrin. J Lab Clin Med 1982; 99:866-72.
12. Kurose I, Yamada T, Wolf R, Granger DN. P-selectin-dependent leukocyte recruitment and intestinal mucosal injury induced by lactoferrin. J Leuk Biol 1994; 55:771-7.
13. Woodhouse LR, Lönnerdal B. Quantification of the major whey proteins in human milk, and development of a technique to isolate minor whey proteins. Nutr Res 1988; 8:853-64.
14. Kijlstra A. The role of lactoferrin in the non-specific immune response on the ocular surface. Reg Immunol 1991; 3:193-7.
15. Britigan BE, Hassett DJ, Rosen GM, Hamill DR, Cohen MS. Neutrophil degranulation inhibits potential hydroxyl radical formation. Biochem J 1989; 264:447-55.
16. Skogh T, Peen E. Lactoferrin and anti-lactoferrin antibodies in inflammatory disease. Adv Exp Med Biol 1993; 336:533-8.
17. Coremans IEM, Hagen EC, Daha MR, van der Woude FJ, van der Voort EAM, Klejburg-van der Keur C, Breedveld FC. Anti-lactoferrin antibodies in patients with rheumatoid arthritis and vasculitis. Arthritis Rheum 1992; 35:1466-75.
18. Peen E, Almer S, Bodemar G, Rydén BO, Sjölin C, Tejle K, Skogh T. Anti-lactoferrin antibodies and other types of 'ANCA' in Crohn's disease, ulcerative colitis, and primary sclerosing cholangitis. Gut 1993; 34:56-62.
19. Ellerbroek PM, Oudkerk Pool M, Ridwan BU et at. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol 1994; 47:257-62.
20. Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease; characterization and clinical correlations. Clin Exp Immunol 1994; 95:490-7.
21. Locht H, Peen E, Skogh T. Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasm antibodies (ANCA) in reactive arthritis and ankylosing spondylitis. Arthritis Rheum 1994; 37:S204.
22. Sundqvist T. Liu SM. Hydrogen peroxide stimulates endocytosis in cultured bovine aortic endothelial cells. Acta Physiol Scand 1993; 149:127-31.
23. Ljunghusen O, Johansson A. Skogh T. Hepatic immune complex elimination studied with FITC-labelled antigen. J Immunol Methods 1990; 128:1-7.
24. Dahlgren C, Magnusson KE, Stendahl O, Sundqvist T. Modulation of polymorphonuclear leukocyte chemiluminescent response to the chemoattractant f-Met-Leu-Phe. Int Archs Allergy Appl Immunol 1982; 68: 79-83.
25. Falk RJ, Terell RS, Charles LA, Jenette JC. Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-9.
26. Charles LA, Caldas ML, Falk RJ, Terrell RS. Jenette JC. Anti-bodies against granule proteins activate neutrophils in vitro. J Leuk Biol 1991;50:539-46.
27. Keogan MT, Esnault VLM, Green AJ, Lockwood CM, Brown DL. Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Cin Exp Immunol 1992;90:228-34.
28. Mulder AHL, Horst G, Limburg PC, Kallenberg CGM. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a FcγRII-dependent process. Clin Exp Immunol 1994; 98:270-8.
29. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FcRγIIa. J Immunol 1994; 153:1271-80.
30. Boxer LA, Stossel TP. Effects of anti-human neutrophil antibodies in vitro. Quantitative studies. J Clin Invest 1973; 53:1534-45.
31. Hadley A, Holburn A. The detection of anti-granulocyte antibodies by chemiluminescence. Clin Lab Hematol 1984; 6:351-61.
32. Brouwer E, Huitema MG, Klok PA, de Weerd H, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Anti-myeloperoxidase associated proliferative glomerulonephritis: an animal model. J Exp Med 1993; 177:905-14.
33. Mayet WJ, Csernok E, Szymkowiak C, Gross WL, Meyer zum Büschenfelde KH. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993; 82:1221-9.
34. Davidson LA, Lönnerdal B. Specific binding of lactoferrin to brushborder membrane: ontogeny and effect of glycan chain. Am J Physiol 1988;254:G580-5.